Rage gene promoter polymorphisms and diabetic retinopathy in a clinic-based population from South India

Eye

Volumn 21, Issue 3, 2007, Pages 395-401

  Ramprasad, S ^a   Radha, V ^a   Mathias, R A ^b   Majumder, P P ^c   Rao, M R S ^d   Rema, M ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c INDIAN STATISTICAL INSTITUTE   (India)

^d INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ADVANCED GLYCATION END PRODUCT RECEPTOR; CYTOSINE; GLUCOSE; TYROSINE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETIC RETINOPATHY; EYE PHOTOGRAPHY; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GLUCOSE TOLERANCE; HAPLOTYPE; HEALTH CARE FACILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; INDIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROLIFERATIVE RETINOPATHY; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 33847649968     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702239     Document Type: Article

References (37)

1. Ceramin A, Vlassara H, Brownlee M. Role of AGE's in complications of diabetes. Diabetes Care 1988; 11: 73-79.
2. Sampathkumar R, Balasubramanyam M, Premanand C, Rema M, Mohan V. Novel Advanced Glycation Index (AGI) and its association with diabetes and Microangiopathy. Metabolism 2005; 54(8): 1002-1007.
3. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318(20): 1315-1321.
4. Horie K, Miyata T, Maeda K, Miyata S, Sugiyanma S, Sakai H et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 1997; 100: 2995-3004.
5. Bierhaus A, Chevion S, Chevion M, Hofmann M, Quehenberger P, Illmer T et al. Advanced glycation end products AGEs induced activation of NF-κB is suppressed by α-lipoic acid in cultured endothelial cells. Diabetes 1997; 46: 1481-1490.
6. Huang JS, Guh JY, Hung WC, Yang ML, Lai YH, Chen HC et al. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells. Biochem J 1999; 342(Part1): 231-238.
7. Vlassara H, Fuh H, Donnelly T, Cybulsky M. Advanced glycation endproducts promote adhesion molecule VCAM-1, ICAM-1 expression and atheroma formation in normal rabbits. Mol Med 1995; 1: 447-456. 196.
8. Bierhaus A, Illmer T, Kasper M, Luther T, Quehenberger P, Tritschler H et al. Advanced glycation endproducts AGEs mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 1997; 96: 2262-2271.
9. The Diabetes Control and Complications Trial Research Group. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 1997; 46(11): 1829-1839.
10. Pyke DA, Tattersall RB. Diabetic retinopathy in identical twins. Diabetes 1972; 22: 613-618.
11. Rema M, Saravanan G, Deepa R, Mohan V. Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients. Diabet Med 2002; 19(11): 910-916.
12. Santos KG, Tschiedel B, Schneider J, Souto K, Roisenberg I. Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: Relationship with polymorphisms in the aldose reductase, the plasminogen activator inhibitor-1 and the methylenetetrahydrofolate reductase genes. Diabetes Res Clin Pract 2003; 61(2): 133-136.
13. Kumaramanickavel G, Sripriya S, Ramprasad VL, Upadyay NK, Paul PG, Sharma T. Z-2 aldose reductase allele and diabetic retinopathy in India. Ophthalmic Genet 2003; 24(1): 41-48.
14. Taverna MJ, Elgrably F, Selmi H; Selam JL, Slama G. The T-786C and C774T endothelial nitric oxide synthase gene polymorphisms independently affect the onset pattern of severe diabetic retinopathy. Nitric Oxide 2005; 13(1): 88-92.
15. Fujita H, Narita T, Meguro H, Ishii T, Hanyu O, Suzuki K et al. Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy. Horm Metab Res 2000; 32(2): 80-83.
16. Zintzaras E, Chatzoulis DZ, Karabatsas CH, Stefanidis I. The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: A meta-analysis. J Hum Genet 2005; 50(6): 267-275. E-pub 2005 May 18.
17. Kumaramanickavel G, Ramprasad VL, Sripriya S, Upadyay NK, Paul PG, Sharma T et al. Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J Diabetes Complications 2002; 16(6): 391-394.
18. Hudson BI, Stickland MH, Futers TS, Grant PJ. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001; 50(6): 1505-1511.
19. Pettersson-Fernholm K, Forsblom C, Hudson BI et al. Finn-Diane Study Group. The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes 2003; 52(3): 891-894.
20. Globocnik Petrovic M, Steblovnik K, Peterlin B et al. The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes. Klin Monatsbl Augenheilkd 2003; 220(12): 873-876.
21. JiXiong X, BiLin X, MingGong Y, ShuQin L. -429T/C and -374T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetes Care 2003; 26(9): 2696-2697.
22. King H, Aubert R, Herman W. Global burden of diabetes, 1995-2025. Prevalence, numericalestimates and projections. Diabetes Care 1998; 21: 1414-1431.
23. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5): 1047-1053.
24. Basu A, Mukherjee N, Roy S, Sengupta S, Banerjee S, Chakraborty M et al. Ethnic India: A genomic view, with special reference to peopling and structure. Genome Res 2003; 13: 2277-2290.
25. Devlin B, Roeder K, Wasserman L. Genomic control, a new approach to genetic-based association studies. Theor Popul Biol 2001; 60: 155-166.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of low density lipoprotein cholesterol without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
27. Varghese A, Deepa R, Rema M, Mohan V. Prevalence of microalbuminuria in Type 2 diabetes mellitus at a diabetes centre in Southern India. Postgraduate Med J 2001; 77: 399-402.
28. Early Treatment of Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic colour fundus photographs - an extension of the modified Airlie House Classification. ETDRS Report 10. Ophthalmology 1991; 98: 786-806.
29. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
30. Fallin D, Schork NJ. Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet 2000; 67: 947-959.
31. Poirier O, Nicaud V, Vionnet N, Raoux S, Tarnow L, Vlassara H et al. Polymorphism screening of four genes encoding advanced glycation end-product putative receptors. Association study with nephropathy in type 1 diabetic patients. Diabetes 2001; 50(5): 1214-1218.
32. Falcone C, Campo I, Emanuele E, Buzzi MP, Geroldi D, Belvito C et al. 374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis. Clin Chim Acta 2005; 354(1-2): 111-116. E-pub 2005 Jan 13.
33. Holla LI, Kankova. K, Fassmann A, Buckova D, Halabala T, Znojil V et al. Distribution of the receptor for advanced glycation end products gene polymorphisms in patients with chronic periodontitis: A preliminary study. J Periodontol 2001; 72(12): 1742-1746.
34. Prevost G, Fajardy I, Besmond C, Balkau B, Tichet J, Fontaine P et al. The Genediab and D.E.S.I.R studies. Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients. Diabetes Metab 2005; 31(1): 35-39.
35. Yoshioka K, Yoshida T, Takakura Y, Umekawa T, Kogure A, Toda H et al. Association study of G1704T and G82S polymorphisms of RAGE gene for microalbuminuria in Japanese type 2 diabetic patients. Metabolism 2005; 54(4): 488-491.
36. Kankova K, Stejskalova A, Hertlova M, Znojil V. Haplotype analysis of the RAGE gene: Identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol Dial Transplant 2005; 20(6): 1093-1102. E-pub 2005 Mar 24.
37. Matsunaga-Irie S, Maruyama T, Yamamoto Y, Motohashi Y, Hirose H, Shimada A et al. Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care 2004; 27(2): 303-307.